Maggie Telfer

541 total citations
13 papers, 404 citations indexed

About

Maggie Telfer is a scholar working on Epidemiology, Public Health, Environmental and Occupational Health and Infectious Diseases. According to data from OpenAlex, Maggie Telfer has authored 13 papers receiving a total of 404 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Epidemiology, 8 papers in Public Health, Environmental and Occupational Health and 5 papers in Infectious Diseases. Recurrent topics in Maggie Telfer's work include HIV, Drug Use, Sexual Risk (10 papers), Opioid Use Disorder Treatment (7 papers) and Substance Abuse Treatment and Outcomes (5 papers). Maggie Telfer is often cited by papers focused on HIV, Drug Use, Sexual Risk (10 papers), Opioid Use Disorder Treatment (7 papers) and Substance Abuse Treatment and Outcomes (5 papers). Maggie Telfer collaborates with scholars based in United Kingdom, Maldives and Saudi Arabia. Maggie Telfer's co-authors include Susan Beckerleg, Matthew Hickman, Gillian Lewando Hundt, Vivian Hope, John Macleod, Fortune Ncube, Mariano Bizzarri, John Parry, Steve Jones and Aaron G. Lim and has published in prestigious journals such as SHILAP Revista de lepidopterología, Addiction and BMJ Open.

In The Last Decade

Maggie Telfer

13 papers receiving 386 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Maggie Telfer United Kingdom 10 326 168 123 97 60 13 404
Dhanya Nambiar Australia 11 368 1.1× 231 1.4× 178 1.4× 60 0.6× 78 1.3× 12 454
Czarina N. Behrends United States 15 387 1.2× 254 1.5× 176 1.4× 53 0.5× 96 1.6× 42 489
Alya Briceño United States 10 427 1.3× 125 0.7× 191 1.6× 195 2.0× 84 1.4× 15 512
Iuliia Makarenko United States 15 428 1.3× 273 1.6× 183 1.5× 70 0.7× 69 1.1× 20 536
Zoë Dodd Canada 10 312 1.0× 98 0.6× 185 1.5× 150 1.5× 103 1.7× 17 462
Jennifer Reed United States 7 535 1.6× 221 1.3× 196 1.6× 287 3.0× 76 1.3× 7 634
Bijan Nassirimanesh Iran 7 402 1.2× 111 0.7× 227 1.8× 131 1.4× 52 0.9× 8 450
Roberto Abadie United States 12 204 0.6× 219 1.3× 102 0.8× 54 0.6× 96 1.6× 39 429
Kristen Ochoa United States 8 461 1.4× 269 1.6× 115 0.9× 160 1.6× 86 1.4× 11 583
Russell Rockwell United States 8 449 1.4× 131 0.8× 221 1.8× 137 1.4× 141 2.4× 14 528

Countries citing papers authored by Maggie Telfer

Since Specialization
Citations

This map shows the geographic impact of Maggie Telfer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maggie Telfer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maggie Telfer more than expected).

Fields of papers citing papers by Maggie Telfer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maggie Telfer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maggie Telfer. The network helps show where Maggie Telfer may publish in the future.

Co-authorship network of co-authors of Maggie Telfer

This figure shows the co-authorship network connecting the top 25 collaborators of Maggie Telfer. A scholar is included among the top collaborators of Maggie Telfer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maggie Telfer. Maggie Telfer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
2.
Kesten, Joanna, Adam Holland, Myles-Jay Linton, et al.. (2021). Living Under Coronavirus and Injecting Drugs in Bristol (LUCID-B): A qualitative study of experiences of COVID-19 among people who inject drugs. International Journal of Drug Policy. 98. 103391–103391. 41 indexed citations
3.
Steer, Colin, John Macleod, Kate Tilling, et al.. (2019). The impact of opiate substitution treatment on mortality risk in drug addicts: a natural experiment study. SHILAP Revista de lepidopterología. 7(3). 1–92. 4 indexed citations
5.
Hickman, Matthew, Colin Steer, Kate Tilling, et al.. (2018). The impact of buprenorphine and methadone on mortality: a primary care cohort study in the United Kingdom. Addiction. 113(8). 1461–1476. 82 indexed citations
7.
Ayres, Rachel, et al.. (2014). Enhancing motivation within a rapid opioid substitution treatment feasibility RCT: a nested qualitative study. Substance Abuse Treatment Prevention and Policy. 9(1). 44–44. 9 indexed citations
8.
Ayres, Rachel, et al.. (2010). Treatment experience and needs of older drug users in Bristol, UK. Journal of Substance Use. 17(1). 19–31. 14 indexed citations
9.
Hope, Vivian, Matthew Hickman, Steve Jones, et al.. (2010). Measuring the incidence, prevalence and genetic relatedness of hepatitis C infections among a community recruited sample of injecting drug users, using dried blood spots. Journal of Viral Hepatitis. 18(4). 262–270. 82 indexed citations
10.
Hickman, Matthew, Vivian Hope, Barbara Coleman, et al.. (2009). Assessing IDU prevalence and health consequences (HCV, overdose and drug-related mortality) in a primary care trust: implications for public health action. Journal of Public Health. 31(3). 374–382. 45 indexed citations
11.
Beckerleg, Susan, et al.. (2006). A Rapid Assessment of Heroin Use in Mombasa, Kenya. Substance Use & Misuse. 41(6-7). 1029–1044. 24 indexed citations
12.
Beckerleg, Susan, Maggie Telfer, & Gillian Lewando Hundt. (2005). The rise of injecting drug use in east Africa: a case study from Kenya. Harm Reduction Journal. 2(1). 12–12. 61 indexed citations
13.
Beckerleg, Susan, et al.. (1996). Private Struggles, Public Support: Rehabilitating heroin users in Kenya. Drugs Education Prevention and Policy. 3(2). 159–169. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026